{
    "Trade/Device Name(s)": [
        "FOCUS Blood Glucose Monitoring System",
        "FOCUS Pro Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Nova Biomedical Corporation",
    "510(k) Number": "K131013",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122435"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "October 17, 2013",
    "Summary Letter Received Date": "October 15, 2013",
    "Submission Date": "April 1, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood",
        "Venous whole blood",
        "Arterial whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FOCUS Blood Glucose Meter",
        "FOCUS Pro Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Coulometric electrochemical sensor",
        "Glucose dehydrogenase - FAD enzymatic method"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Electrochemical analysis"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for Nova Biomedical FOCUS and FOCUS Pro blood glucose monitoring systems for quantitative glucose measurement in whole blood using electrochemical sensor technology",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in whole blood for self-testing (FOCUS) or multi-patient/professional use (FOCUS Pro) as an aid in monitoring diabetes control; not for diagnosis or neonatal use",
    "fda_folder": "Clinical Chemistry"
}